A novel cerebello-ocular syndrome with abnormal glycosylation due to abnormalities in dolichol metabolism
- 17 September 2010
- journal article
- research article
- Published by Oxford University Press (OUP) in Brain
- Vol. 133 (11), 3210-3220
- https://doi.org/10.1093/brain/awq261
Abstract
Cerebellar hypoplasia and slowly progressive ophthalmological symptoms are common features in patients with congenital disorders of glycosylation type I. In a group of patients with congenital disorders of glycosylation type I with unknown aetiology, we have previously described a distinct phenotype with severe, early visual impairment and variable eye malformations, including optic nerve hypoplasia, retinal coloboma, congenital cataract and glaucoma. Some of the symptoms overlapped with the phenotype in other congenital disorders of glycosylation type I subtypes, such as vermis hypoplasia, anaemia, ichtyosiform dermatitis, liver dysfunction and coagulation abnormalities. We recently identified pathogenic mutations in the SRD5A3 gene, encoding steroid 5α-reductase type 3, in a group of patients who presented with this particular phenotype and a common metabolic pattern. Here, we report on the clinical, genetic and metabolic features of 12 patients from nine families with cerebellar ataxia and congenital eye malformations diagnosed with SRD5A3-congenital disorders of glycosylation due to steroid 5α-reductase type 3 defect. This enzyme is necessary for the reduction of polyprenol to dolichol, the lipid anchor for N-glycosylation in the endoplasmic reticulum. Dolichol synthesis is an essential metabolic step in protein glycosylation. The current defect leads to a severely abnormal glycosylation state already in the early phase of the N-glycan biosynthesis pathway in the endoplasmic reticulum. We detected high expression of SRD5A3 in foetal brain tissue, especially in the cerebellum, consistent with the finding of the congenital cerebellar malformations. Based on the overlapping clinical, biochemical and genetic data in this large group of patients with congenital disorders of glycosylation, we define a novel syndrome of cerebellar ataxia associated with congenital eye malformations due to a defect in dolichol metabolism.This publication has 42 references indexed in Scilit:
- Congenital disorder of glycosylation (CDG)-Ih patient with a severe hepato-intestinal phenotype and evolving central nervous system pathologyThe Journal of Pediatrics, 2005
- Biosynthesis of Lipid-linked Oligosaccharides in Saccharomyces cerevisiaePublished by Elsevier BV ,2005
- Cerebral, cerebellar, and colobomatous anomalies in three related males: Sex‐linked inheritance in a newly recognized syndrome with features overlapping with Joubert syndromeAmerican Journal of Medical Genetics Part A, 2005
- Congenital disorder of glycosylation (CDG) type Ie. A new patientJournal of Inherited Metabolic Disease, 2004
- A New Type of Congenital Disorders of Glycosylation (CDG-Ii) Provides New Insights into the Early Steps of Dolichol-linked Oligosaccharide BiosynthesisJournal of Biological Chemistry, 2003
- A new case of CDG‐x with stereotyped dystonic hand movements and optic atrophyJournal of Inherited Metabolic Disease, 2002
- A New Subtype of a Congenital Disorder of Glycosylation (CDG) with Mild Clinical ManifestationsNeuropediatrics, 2001
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- A broad spectrum of clinical presentations in congenital disorders of glycosylation I: a series of 26 casesJournal of Medical Genetics, 2001
- Optimized Separation and Quantitation of Serum and Cerebrospinal Fluid Transferrin Subfractions Defined by Differences in Iron Saturation or Glycan CompositionAdvances in Experimental Medicine and Biology, 1994